Evidence map›Paper›PMID 28283832›Full record

ArticleHuman genetics2017

Genetic and phenotypic dissection of 1q43q44 microdeletion syndrome and neurodevelopmental phenotypes associated with mutations in ZBTB18 and HNRNPU.

Christel Depienne, Caroline Nava, Boris Keren, Solveig Heide, Agnès Rastetter, Sandrine Passemard, Sandra Chantot-Bastaraud, Marie-Laure Moutard, Pankaj B Agrawal, Grace VanNoy and 52 more

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Identification of De NovoInternational journal of pediatrics · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

62 authors at 20 institutions in 13 countries.

Christel DepienneIGBMC, CNRS UMR 7104/INSERM U964/Université de Strasbourg, 67400, Illkirch, France. depiennc@igbmc.fr.
Caroline NavaINSERM, U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, 75013, Paris, France.
Boris KerenINSERM, U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, 75013, Paris, France.
Solveig HeideAP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France.
Agnès RastetterINSERM, U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, 75013, Paris, France.
Sandrine PassemardAP-HP, Department of Child Neurology, Hôpital Robert Debré, Paris, France.
Sandra Chantot-BastaraudAP-HP, Département de Génétique Médicale, Unité fonctionnelle de Génétique Chromosomique, CHU Paris Est, Hôpital d'Enfants Armand-Trousseau, 75571, Paris, France.
Marie-Laure MoutardAP-HP, Service de Neuropédiatrie, Hôpital Trousseau, 75012, Paris, France.
Pankaj B AgrawalDivisions of Genetics and Genomics and Newborn Medicine, Manton Center for Orphan Disease Research, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
Grace VanNoyDivisions of Genetics and Genomics and Newborn Medicine, Manton Center for Orphan Disease Research, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
Joan M StolerDivisions of Genetics and Genomics and Newborn Medicine, Manton Center for Orphan Disease Research, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
David J AmorMurdoch Childrens Research Institute, Royal Children's Hospital, Parkville, VIC, 3052, Australia.
Thierry Billette de VillemeurINSERM UMR U1141, Hôpital Robert Debré, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
Diane DoummarAP-HP, Service de Neuropédiatrie, Hôpital Trousseau, 75012, Paris, France.
Caroline AlbyINSERM U1163, Laboratory of Embryology and Genetics of Congenital Malformations, Sorbonne Paris Cité and Imagine Institute, Paris Descartes University, 75015, Paris, France.
Valérie Cormier-DaireINSERM U1163, Laboratory of Molecular and Physiopathological bases of osteochondrodysplasia, Sorbonne Paris Cité and Imagine Institute, Paris Descartes University, 75015, Paris, France.
Catherine GarelAP-HP, GHUEP, Service de Radiologie, Hôpital Armand-Trousseau, 75012, Paris, France.
Pauline MarzinAP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France.
Sophie ScheideckerLaboratoires de Génétique, Institut de Génétique médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, 67000, Strasbourg, France.
Anne de Saint-MartinIGBMC, CNRS UMR 7104/INSERM U964/Université de Strasbourg, 67400, Illkirch, France.
Edouard HirschIGBMC, CNRS UMR 7104/INSERM U964/Université de Strasbourg, 67400, Illkirch, France.
Christian KorffDépartement de l'Enfant et de l'Adolescent, Neuropédiatrie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Armand BottaniService de Médecine génétique, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Laurence FaivreEquipe d'Accueil 4271, Génétique des Anomalies du Développement, Université de Bourgogne, 21079, Dijon, France.
Alain VerloesAP-HP, Department of Genetics, Hôpital Robert Debré, Paris, France.
Christine OrzechowskiService de Pédiatrie, Hôpital Saint-Camille Bry-sur-Marne, Le Chesnay, France.
Lydie BurglenINSERM UMR U1141, Hôpital Robert Debré, Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
Bruno LeheupService de génétique clinique, Hôpital de Brabois, CHU de Nancy, Nancy, France.
Joelle RoumeDepartment of Genetics, Poissy-Saint-Germain-en-Laye Hospital, Poissy, France.
Joris AndrieuxInstitut de Génétique Médicale, CHRU de Lille, Lille, France.
Frenny ShethDepartment of Cytogenetics and Molecular Cytogenetics, FRIGE's Institute of Human Genetics, FRIGE House, Satellite, Ahmedabad, India.
Chaitanya DatarSahyadari Medical Genetics and Tissue engineering facility (SMGTEF), Pune, 411005, India.
Michael J ParkerSheffield Clinical Genetics Service, OPD2, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK.
Laurent PasquierService de Génétique Clinique, CHU de Rennes, Rennes, France.
Sylvie OdentService de Génétique Clinique, CHU de Rennes, Rennes, France.
Sophie NaudionService de Génétique Médicale, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.
Marie-Ange DelrueService de Génétique Médicale, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.
Cédric Le CaignecService de Génétique Médicale, CHU de Nantes, Nantes, France.
Marie VincentService de Génétique Médicale, CHU de Nantes, Nantes, France.
Bertrand IsidorService de Génétique Médicale, CHU de Nantes, Nantes, France.
Florence RenaldoAP-HP, Department of Child Neurology, Hôpital Robert Debré, Paris, France.
Fiona StewartNorthern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, Ireland.
Annick ToutainService de Génétique Médicale, CHU Tours, Tours, France.
Udo KoehlerMedizinisch Genetisches Zentrum, 80335, Munich, Germany.
Birgit HäcklHospital for Neuropediatrics and Neurological Rehabilitation, Epilepsy Center for Children and Adolescents, 83569, Vogtareuth, Germany.
Celina von StülpnagelHospital for Neuropediatrics and Neurological Rehabilitation, Epilepsy Center for Children and Adolescents, 83569, Vogtareuth, Germany.
Gerhard KlugerHospital for Neuropediatrics and Neurological Rehabilitation, Epilepsy Center for Children and Adolescents, 83569, Vogtareuth, Germany.
Rikke S MøllerThe Danish Epilepsy Centre, Dianalund, Denmark.
Deb PalDepartment of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK.
Tord JonsonDepartment of Clinical Genetics, University and Regional Laboratories, Skåne University Hospital, Lund University, Lund, Sweden.
Maria SollerDepartment of Clinical Genetics, Lund University Hospital, 221 85, Lund, Sweden.
Nienke E VerbeekDepartment of Genetics, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.
Mieke M van HaelstDepartment of Genetics, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.
Carolien de KovelDepartment of Genetics, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.
Bobby KoelemanDepartment of Genetics, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.
Glen MonroeDepartment of Genetics, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.
Gijs van HaaftenDepartment of Genetics, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.
DDD Study
Tania Attié-BitachINSERM U1163, Laboratory of Embryology and Genetics of Congenital Malformations, Sorbonne Paris Cité and Imagine Institute, Paris Descartes University, 75015, Paris, France.
Lucile BoutaudINSERM U1163, Laboratory of Embryology and Genetics of Congenital Malformations, Sorbonne Paris Cité and Imagine Institute, Paris Descartes University, 75015, Paris, France.
Delphine HéronAP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France.
Cyril MignotAP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, 75013, Paris, France. cyril.mignot@aphp.fr.
Centre National de la Recherche Scientifique · FRInserm · FRDélégation Paris 5 · FRSorbonne Université · FRUniversity Medical Center Utrecht · NLBoston Children's Hospital · USSchön Klinik Vogtareuth · DECentre Hospitalier Universitaire de Lille · FRLund University · SENorthern General Hospital · GBUniversité de Bourgogne · FRUniversity of Southern Denmark · DKUniversity of Ulster · GBAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Tours · FRCIC Rennes · FREuropean Organisation for Rare Diseases · FRHôpital Beau-Séjour · CH

Funding

Medical Research Council MR/N026063/1
6 · The paper itself

Abstract

Subtelomeric 1q43q44 microdeletions cause a syndrome associating intellectual disability, microcephaly, seizures and anomalies of the corpus callosum. Despite several previous studies assessing genotype-phenotype correlations, the contribution of genes located in this region to the specific features of this syndrome remains uncertain. Among those, three genes, AKT3, HNRNPU and ZBTB18 are highly expressed in the brain and point mutations in these genes have been recently identified in children with neurodevelopmental phenotypes. In this study, we report the clinical and molecular data from 17 patients with 1q43q44 microdeletions, four with ZBTB18 mutations and seven with HNRNPU mutations, and review additional data from 37 previously published patients with 1q43q44 microdeletions. We compare clinical data of patients with 1q43q44 microdeletions with those of patients with point mutations in HNRNPU and ZBTB18 to assess the contribution of each gene as well as the possibility of epistasis between genes. Our study demonstrates that AKT3 haploinsufficiency is the main driver for microcephaly, whereas HNRNPU alteration mostly drives epilepsy and determines the degree of intellectual disability. ZBTB18 deletions or mutations are associated with variable corpus callosum anomalies with an incomplete penetrance. ZBTB18 may also contribute to microcephaly and HNRNPU to thin corpus callosum, but with a lower penetrance. Co-deletion of contiguous genes has additive effects. Our results confirm and refine the complex genotype-phenotype correlations existing in the 1qter microdeletion syndrome and define more precisely the neurodevelopmental phenotypes associated with genetic alterations of AKT3, ZBTB18 and HNRNPU in humans.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 1MutationPhenotypeHeterogeneous-Nuclear RibonucleoproteinsHumansNeurodevelopmental DisordersRepressor ProteinsHeterogeneous-Nuclear RibonucleoproteinsRepressor ProteinsZBTB18 protein, human

Identifiers

PMID28283832
PMCPMC5360844
OpenAlexW2591741230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.